DBCO-PEG4-Glu-Gly-Cit-PAB-MMAE is a precursor for an antibody-drug conjugate (ADC) with a cleavable Glu-Gly-Cit (EGCit) peptide and a click-reactive DBCO for attaching to azide-containing compounds or anitbodies. It exhibits robust stability, resisting degradation and neutrophil protease cleavage while delivering payloads within cells discreetly and tracelessly.
Usually ships within 24 hours.